XML 68 R49.htm IDEA: XBRL DOCUMENT v3.20.4
RediTrex® and Vibativ® - Narrative (Details) - USD ($)
shares in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Nov. 30, 2016
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2021
Business Acquisition [Line Items]                          
Revenue from Contract with Customer, Excluding Assessed Tax                   $ 35,840,673 $ 32,407,845 $ 28,803,961  
Other revenue, potential upfront payment related to product sales                   4,800,000      
Payments to acquire businesses                   0 5,000,000 20,000,000  
Net revenues from customers outside the United States   $ 10,261,534 $ 9,250,689 $ 9,598,177 $ 8,330,734 $ 9,305,553 $ 6,935,439 $ 9,417,443 $ 8,729,860 37,441,134 34,388,295 29,344,894  
Nordic Group B.V.                          
Business Acquisition [Line Items]                          
Net revenues from customers outside the United States   500,000                      
Methotrexate                          
Business Acquisition [Line Items]                          
Payments to acquire businesses $ 100,000                        
Liabilities incurred $ 900,000                        
Stock issued during period, acquisitions                   900,000      
Intellectual property amortizable intangible assets   $ 2,800,000               2,800,000      
Methotrexate | Subsequent Event                          
Business Acquisition [Line Items]                          
Liability to be paid                         $ 1,000,000.0
Omeclamox-Pak                          
Business Acquisition [Line Items]                          
Revenue from Contract with Customer, Excluding Assessed Tax                   $ 257,088 $ 837,829 $ 623,297  
Restricted Stock | Methotrexate                          
Business Acquisition [Line Items]                          
Stock issued during period, acquisitions (in shares) 180